PLSE insider transaction filings

PULSE BIOSCIENCES, INC. — 26 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-06-15. Screen PLSE transaction legs live →

FiledFormInsiderReported transactionsSource
2026-06-154Soni Manmeet Singh — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-154Zanganeh Mahkam — DirectorGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 14,504 (derivative) @ $0EDGAR
2026-06-154Sainz Maria — DirectorGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 3,793 (derivative) @ $0EDGAR
2026-06-154van den Broek Richard — DirectorGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 8,423 (derivative) @ $0EDGAR
2026-06-154DUGGAN ROBERT W — Director, 10% ownerGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 12,495 (derivative) @ $0EDGAR
2026-05-154/ADUGGAN ROBERT W — Director, 10% ownerPurchase (P): 660,233 @ $19.69EDGAR
2026-05-114LAVIOLETTE PAUL A — Chief Executive Officer, DirectorPurchase (P): 15,000 @ $19.69EDGAR
2026-05-114/ALAVIOLETTE PAUL A — Chief Executive Officer, DirectorPurchase (P): 15,000 @ $19.69EDGAR
2026-05-114DUGGAN ROBERT W — Director, 10% ownerPurchase (P): 660,233 @ $19.69EDGAR
2026-04-034UECKER DARRIN — Chief Technology Officer, DirectorGrant/award (A): 100,000 (derivative) @ $0EDGAR
2026-02-234Danahy Kevin Patrick — Chief Commercial OfficerOption exercise (M): 5,000 @ $1.53 · Sale (S): 5,000 @ $23.64 · Option exercise (M): 5,000 (derivative) @ $0EDGAR
2026-02-174Danahy Kevin Patrick — Chief Commercial OfficerOption exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.37 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.53 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.63 · +3 moreEDGAR
2026-02-114Danahy Kevin Patrick — Chief Commercial OfficerOption exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $21.45 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $23.52 · Option exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $25.20 · +3 moreEDGAR
2026-02-064Sainz Maria — DirectorGrant/award (A): 50,000 (derivative) @ $0 · Grant/award (A): 3,104 (derivative) @ $0EDGAR
2025-10-074Danahy Kevin Patrick — Chief Commercial OfficerOption exercise (M): 4,600 @ $1.53 · Sale (S): 4,600 @ $18.53 · Option exercise (M): 4,600 (derivative) @ $0EDGAR
2025-09-224Danahy Kevin Patrick — Chief Commercial OfficerOption exercise (M): 20,000 @ $1.53 · Sale (S): 20,000 @ $18.49 · Option exercise (M): 400 @ $1.53 · Sale (S): 400 @ $18.48 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 400 (derivative) @ $0EDGAR
2025-09-184UECKER DARRIN — Chief Technology Officer, DirectorOption exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $16.28 · Option exercise (M): 20,000 @ $4 · Sale (S): 20,000 @ $16.21 · Option exercise (M): 61,534 @ $4 · Option exercise (M): 100,000 @ $4 · +4 moreEDGAR
2025-09-154UECKER DARRIN — Chief Technology Officer, DirectorOption exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $14.78 · Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $14.32 · Option exercise (M): 25,000 @ $4 · Sale (S): 25,000 @ $15.77 · +3 moreEDGAR
2025-09-124DUGGAN ROBERT W — Director, 10% ownerPurchase (P): 34,659 @ $14.66 · Purchase (P): 12,800 @ $14.77 · Purchase (P): 145,140 @ $14.41EDGAR
2025-08-194Soni Manmeet Singh — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-08-194Zanganeh Mahkam — DirectorGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 24,134 (derivative) @ $0EDGAR
2025-08-194van den Broek Richard — DirectorGrant/award (A): 30,000 (derivative) @ $0EDGAR
2025-08-194DUGGAN ROBERT W — Director, 10% ownerGrant/award (A): 30,000 (derivative) @ $0 · Grant/award (A): 20,792 (derivative) @ $0EDGAR
2025-07-164Weber Steven — Principal Accounting OfficerGrant/award (A): 55,000 (derivative) @ $0EDGAR
2025-06-164UECKER DARRIN — Chief Technology Officer, DirectorSale (S): 15,000 @ $16.40 · Sale (S): 15,000 @ $15.98EDGAR
2025-02-114Zanganeh Mahkam — DirectorOption exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 @ $11 · Option exercise/expiry (X): 30,121 (derivative) @ $0 · Option exercise/expiry (X): 30,121 (derivative) @ $0EDGAR

Recent 8-K events — PULSE BIOSCIENCES, INC.

FiledFormItems reportedSource
2026-08-068-K1.01 — Entry into a Material Definitive Agreement
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-068-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-07-298-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-06-128-K5.07 — Submission of Matters to a Vote of Security HoldersEDGAR
2026-06-108-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-05-068-K8.01 — Other EventsEDGAR
2026-05-048-K2.02 — Results of Operations and Financial Condition
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-278-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-168-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-04-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=PLSE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →